07 Mar 2024 --- Valisure finds that benzene, a known human carcinogen, can form at high levels in benzoyl peroxide (BPO) acne treatment products. The independent quality assurance provider is petitioning the FDA “to issue a regulation, revise industry guidance, request a recall and suspend sales of benzoyl peroxide from the US market.”
